A COMPARATIVE STUDY ON THE SAFETY AND EFFICACY OF TOPICAL BIMATOPROST WITH TIMOLOL MALEATE IN GLAUCOMA PATIENTS

被引:0
|
作者
Polagani, Padma [1 ]
Maddikunta, Sridhar Venkat [2 ]
Balakrishna, Namala [2 ]
Kondaveti, Souris [2 ]
机构
[1] Kakatiya Med Coll, Dept Pharmacol, Warangal, Telangana, India
[2] Osmania Med Coll & Hosp, Dept Pharmacol, Hyderabad, Telangana, India
关键词
IOP; PACG; POAG; Bimatoprost; Timolol Maleate;
D O I
10.14260/jemds/2016/670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Glaucoma is a group of disorders characterized by increase in Intraocular Pressure OOP), which can damage the optic nerve and if untreated can lead to gradual peripheral vision loss and irreversible blindness. Glaucoma classified into primary and secondary glaucoma. Primary glaucoma has two types Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG). Glaucoma is the second leading cause of blindness. Worldwide, it is estimated that about 66.8 million people have visual impairment from glaucoma with 6.8 million suffering from blindness. AIMS AND OBJECTIVE To assess the level of IOP reduction of bimatoprost with timolol maleate and its statistical analysis. To compare the IOP lowering efficacy of bimatoprost with timolol maleate. To study the adverse drug reaction profiles of both the drugs. MATERIALS AND METHODS This study was designed to compare the efficacy and safety of topical anti-glaucoma drugs, Bimatoprost (0.03%) and Timolol maleate (0.5%) in patients with POAG attending at Regional Eye Hospital, Warangal. RESULTS In this study mean reduction of IOP at 2 wks., 6 wks., 12 wks., 24 wks. were 6.60 mmHg (23.21%), 9.6 mmHg (33.76%), 10.00 mmHg (38.68%), 11.20 mmHg (39.39%) for Bimatoprost and 4.20 mmHg (15.07%), 6.24% mmHg (23.39%), 7.36 mmHg (25.91%) and 7.64 mmHg (26.56%) for Timolol group respectively. STATISTICAL METHOD Student's 't' test was used for analysis of results. CONCLUSION Bimatoprost 0.03% ophthalmic solution was highly efficacious, well tolerated, systemically safe and minimal ocular side effects and less drug withdraw. It can be used as first line therapy to treat cases of POAG to reduce IOP. The only limitation for its use is regarding its cost. The topical bimatoprost preparations are expensive when compared to the topical Timolol maleate. But considering the reduction in IOP, the modifiable factor for preventing the progression of optic nerve head damage and preservation of visual function hence increase the quality of vision and life.
引用
收藏
页码:2974 / 2979
页数:6
相关论文
共 50 条
  • [31] Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas
    Tong, Shuang
    Xu, Da-Peng
    Liu, Zi-Mei
    Du, Yang
    Wang, Xu-Kai
    ONCOLOGY LETTERS, 2016, 12 (03) : 1806 - 1810
  • [32] Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension
    Kaluzny, Jozef
    Sobecki, Roman
    Czechowicz-Janicka, Krystyna
    Kecik, Dariusz
    Kaluzny, Bartlomiej J.
    Stewart, Jeanette A.
    Stewart, William C.
    ACTA OPHTHALMOLOGICA, 2008, 86 (08) : 860 - 865
  • [33] Efficacy and Safety of Latanoprost Versus the Pilocarpine/Timolol Maleate Fixed Combination in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
    Kaluzny, J.
    Sobecki, R.
    Czechowicz-Janicka, K.
    Kecik, D.
    Stewart, J. A.
    Stewart, W. C.
    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 143 - +
  • [34] The long-term safety and efficacy of timolol maleate gel forming solution in patients with open-angle glaucoma or ocular hypertension
    Silver, LH
    Garadi, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S513 - S513
  • [35] TIMOLOL - REVIEW OF ITS THERAPEUTIC EFFICACY IN THE TOPICAL TREATMENT OF GLAUCOMA
    HEEL, RC
    BROGDEN, RN
    SPEIGHT, TM
    AVERY, GS
    DRUGS, 1979, 17 (01) : 38 - 55
  • [36] Efficacy of latanoprost and timolol maleate in black and white patients
    Naris Kitnarong
    Yuling Zhao
    Peter A. Netland
    Alexander R. Kent
    Advances in Therapy, 2004, 21 : 203 - 213
  • [37] Efficacy of latanoprost and timolol maleate in black and white patients
    Kitnarong, N
    Zhao, YL
    Netland, PA
    Kent, AR
    ADVANCES IN THERAPY, 2004, 21 (04) : 203 - 213
  • [38] Brimonidine purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension
    Netland, PA
    Mroz, M
    Rosner, SA
    Katzman, B
    Macy, JI
    ADVANCES IN THERAPY, 2003, 20 (01) : 20 - 30
  • [39] 2-year comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension
    Cohen, JS
    Gross, RL
    Sherwood, MB
    Cheetham, JK
    VanDenburgh, A
    Bernstein, P
    Whitcup, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U371 - U371
  • [40] Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension
    Peter A. Netland
    Michael Mroz
    Sarah A. Rosner
    Barry Katzman
    Jonathan I. Macy
    Advances in Therapy, 2003, 20 : 20 - 30